Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD133+ Stem Cell Implantation in CABG Patients
NCT02870933Phase 4Completed
- Sponsor
- National Cardiovascular Center Harapan Kita
- Start
- Jan 2016
- Primary completion
- Apr 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of autologous CD133+ cells in coronary artery disease (CAD), heart failure (HF), sponsored by National Cardiovascular Center Harapan Kita. Started Jan 2016; status: completed.
02
Drugs
autologous CD133+ cells
03
Conditions
coronary artery disease (CAD)heart failure (HF)
Beyond the preview
Go deeper on NCT02870933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870933.